BeStock  

Acadia Healthcare ACHC

US equityMarket cap rank #2381Medical Care Facilities
$34.60 +$0.13 (+0.38%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $34.60 0.00%
Open$33.91
Prev close$34.47
Day range$33.80 – $35.15
Volume1.92M
Market cap$3.22B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$895.31M+5.1% YoY
Operating profit$114.07M-4.6% YoY
Net profit$38.65M+0.9% YoY
Diluted EPS$0.38-5.0% YoY
Free cash flow$47.14M+174.8% YoY
Operating cash flow$97.88M

Revenue, last 8 quarters

$774.2MDec '24$770.5MMar '25$869.2MJun '25$851.6MSep '25$821.5MDec '25$828.8MMar '26$865.8MJun '26$895.3MSep '26

Net profit, last 8 quarters

$33.5MDec '24$9.1MMar '25$37.9MJun '25$38.3MSep '25$-1.2BDec '25$4.5MMar '26$12.3MJun '26$38.7MSep '26

Diluted EPS by quarter

0.35Dec '240.09Mar '250.33Jun '250.40Sep '25-13.02Dec '250.05Mar '260.12Jun '260.38Sep '26

Free cash flow by quarter

$-86.8MDec '24$-163.2MMar '25$-34.2MJun '25$-63.0MSep '25$-179.5MDec '25$-15.0MMar '26$123.5MJun '26$47.1MSep '26

Annual revenue

$2.1BFY20$2.3BFY21$2.6BFY22$2.9BFY23$3.2BFY24$3.3BFY25

Profitability & balance sheet

Gross margin96.4%
Operating margin9.8%
Net margin-33.1%
Return on equity-43.9%
Return on assets-18.9%
Return on invested capital-20.6%
Current ratio1.60
Liabilities / assets59.5%
Cash & investments$163.31M
Total debt$2.48B
Net cash (debt)-$2.32B

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $895.31M $865.84M $828.80M $3.31B $821.46M
Total Operating Revenue $895.31M $865.84M $828.80M $3.31B $821.46M
Cost of Revenue $31.50M $30.20M $29.49M $118.05M $30.76M
Gross Profit $863.81M $835.64M $799.31M $3.19B $790.70M
Operating Expense $749.74M $747.87M $715.48M $2.81B $743.05M
Selling and Admin Expenses $560.86M $541.70M $531.97M $2.06B $521.20M
-General & Admin Expense $560.86M $541.70M $531.97M $2.06B $521.20M
Depreciation & Amortization & Depletion $53.13M $50.43M $52.43M $189.25M $45.75M
-Depreciation & Amortization $53.13M $50.43M $52.43M $189.25M $45.75M
Other Operating Expenses $135.74M $155.75M $131.08M $553.31M $176.11M
Operating Profit $114.07M $87.77M $83.84M $387.97M $47.64M
Net Non-Operating Interest Income (Expense) -$37.28M -$38.18M -$38.33M -$138.86M -$37.93M
Non-Operating Interest Expense $37.28M $38.18M $38.33M $138.86M $37.93M
Other Income (Expense) -$20.32M -$27.58M -$34.54M -$1.32B -$1.18B
Special Income (Charges) -$20.32M -$27.58M -$34.54M -$1.32B -$1.18B
-Less:Restructuring and Mergern & Acquisition $5.47M $15.11M $9.59M $28.37M $13.23M
-Less:Impairment of Capital Assets $3.55M – – – –
-Less:Other Special Charges $11.12M $7.47M $26.17M $287.49M $159.45M
-Gain on Sale of Property/Plant/Equipment -$189,000.00 $2.36M $1.22M $8.72M $0.00
Pretax Profit $56.47M $22.01M $10.96M -$1.07B -$1.17B
Tax $17.82M $9.75M $6.50M $25.98M $7.84M
Net Profit $38.65M $12.26M $4.46M -$1.09B -$1.18B
Profit from Continuing Operations $38.65M $12.26M $4.46M -$1.09B -$1.18B
Minority Interests $4.16M $1.33M $359,000.00 $10.85M $279,000.00
Net Income to Parent Company $34.49M $10.93M $4.11M -$1.10B -$1.18B
Net Income to Common Stockholders $34.49M $10.93M $4.11M -$1.10B -$1.18B
Basic EPS $0.38 $0.12 $0.05 -$12.16 -$13.02
Diluted EPS $0.38 $0.12 $0.05 -$12.16 -$13.02
-Less:Write Off – $7.36M – $1.01B –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $5.55B $5.55B $5.55B $5.53B $5.53B
Total Current Assets $881.32M $845.29M $837.20M $814.14M $814.14M
Cash and Cash Equivalents & Short-Term Investments $163.31M $171.29M $158.47M $133.24M $133.24M
-Cash and Cash Equivalents $163.31M $171.29M $158.47M $133.24M $133.24M
Receivables $561.59M $555.49M $547.73M $545.16M $545.16M
-Accounts Receivable $501.39M $470.75M $471.75M $440.60M $440.60M
-Taxes Receivable $39.12M $49.55M $46.76M $41.89M $41.89M
-Other Receivables $21.08M $35.19M $29.22M $62.67M $62.67M
Prepaid Assets $73.30M $54.08M $56.82M $65.52M $65.52M
Inventory $6.25M $6.26M $5.93M $5.69M $5.69M
Other Current Assets $5.67M $5.55M $6.14M $4.12M $4.12M
Total Non-Current Assets $4.67B $4.70B $4.71B $4.71B $4.71B
Net PPE $3.19B $3.23B $3.24B $3.25B $3.25B
-Gross PPE $4.33B $4.32B $4.29B $4.25B $4.25B
-Accumulated Depreciation -$1.14B -$1.09B -$1.05B -$1.01B -$1.01B
Goodwill and Other Intangible Assets $1.42B $1.40B $1.40B $1.39B $1.39B
-Goodwill $1.32B $1.30B $1.30B $1.30B $1.30B
-Other Intangible Assets $100.19M $100.19M $98.59M $96.67M $96.67M
Non-Current Deferred Assets $2.42M $2.46M $2.49M $2.53M $2.53M
Other Non-Current Assets $67.24M $66.40M $67.97M $72.55M $72.55M
Total Liabilities $3.30B $3.35B $3.38B $3.39B $3.39B
Total Current Liabilities $552.03M $537.58M $489.36M $525.19M $525.19M
Payables $155.34M $151.92M $156.05M $163.93M $163.93M
-Accounts Payable $138.56M $135.26M $142.20M $150.40M $150.40M
-Total Tax Payable $16.79M $16.67M $13.85M $13.53M $13.53M
Current Accrued Expenses $339.15M $328.13M $275.74M $307.77M $307.77M
Short-Term Debt and Capital Lease Obligation $55.33M $54.34M $54.32M $50.69M $50.69M
-Current Debt $32.50M $32.50M $32.50M $28.44M $28.44M
-Current Capital Lease Obligation $22.83M $21.84M $21.82M $22.25M $22.25M
Current Deferred Liabilities $2.21M $3.18M $3.24M $2.81M $2.81M
Total Non-Current Liabilities $2.75B $2.82B $2.89B $2.86B $2.86B
Long Term Debt and Capital Lease Obligation $2.45B $2.51B $2.62B $2.59B $2.59B
-Long Term Debt $2.32B $2.38B $2.49B $2.47B $2.47B
-Long Term Capital Lease Obligation $129.55M $128.85M $121.36M $121.96M $121.96M
Non-Current Deferred Liabilities $93.64M $87.14M $76.91M $66.61M $66.61M
Other Non-Current Liabilities $207.15M $218.84M $196.27M $201.61M $201.61M
Total Equity $2.25B $2.19B $2.17B $2.14B $2.14B
Stockholders' Equity $2.02B $1.98B $1.96B $1.95B $1.95B
Capital Stock $909,000.00 $909,000.00 $908,000.00 $905,000.00 $905,000.00
-Common Stock $909,000.00 $909,000.00 $908,000.00 $905,000.00 $905,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.74B $2.73B $2.72B $2.71B $2.71B
Retained Earnings -$716.32M -$750.81M -$761.74M -$765.84M -$765.84M
Minority Interests $229.88M $212.73M $209.98M $191.59M $191.59M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $97.88M $162.07M $61.53M $131.90M -$86.29M
Net cash flow from continuing operations $97.88M $162.07M $61.53M $131.90M -$86.29M
Net Income from Continuing Operations $38.65M $12.26M $4.46M -$1.09B -$1.18B
Gain/Loss from Continuing Operations $189,000.00 -$2.36M -$1.22M -$7.45M $0.00
Depreciation & Depletion & Amortization $53.13M $50.43M $52.43M $189.25M $45.75M
Deferred Tax $6.54M $10.26M $10.34M $1.09M -$2.22M
Other Non-Cash Items $1.40M $1.38M $1.65M $9.99M $1.07M
Change in Working Capital -$14.82M $71.74M -$14.09M -$8.67M $33.45M
-Change in Receivables -$30.64M $1.00M -$31.15M -$75.02M -$10.07M
-Change in Payables and Accrued Expense $6.61M $29.73M -$10.17M $41.56M $2.82M
-Change in Other Current Assets $12.23M $2.83M $26.96M -$58.50M -$30.05M
-Change in Other Current Liabilities -$3.03M $38.18M $270,000.00 $83.30M $70.74M
Net cash flow from investing -$42.51M -$32.68M -$60.21M -$556.21M -$92.44M
Net Cash Flow from Continuing Investing Activities -$42.51M -$32.68M -$60.21M -$556.21M -$92.44M
Capital Expenditure -$50.74M -$38.55M -$76.56M -$571.81M -$93.19M
Net PPE Purchase and Sale $7.40M $10.11M $16.38M $23.85M $697,000.00
Net Business Purchase and Sale $0.00 $0.00 $0.00 -$8.17M $0.00
Net Other Investing Changes $831,000.00 -$4.24M -$30,000.00 -$90,000.00 $55,000.00
Financing Cash Flow -$63.36M -$116.57M $23.91M $481.25M $193.28M
Net Cash Flow from Continuing Financing Activities -$63.36M -$116.57M $23.91M $481.25M $193.28M
Net Issuance Payments Of Debt -$63.13M -$113.13M $25.94M $550.96M $189.94M
Net Common Stock Issuance $0.00 $0.00 $0.00 -$50.03M $0.00
Net Other Financing Charges -$233,000.00 -$3.45M -$2.03M -$19.67M $3.34M
Ending Cash Balance $163.31M $171.29M $158.47M $133.24M $133.24M
Net Change in Cash -$7.98M $12.82M $25.23M $56.94M $14.55M
Beginning Cash Balance $171.29M $158.47M $133.24M $76.31M $118.69M
Free Cash Flow $47.14M $123.51M -$15.03M -$439.91M -$179.48M

Discussion

No comments yet — be the first to weigh in on ACHC.

Sign in to join the discussion.

Scroll to Top